Osteogenic injectable bone substitutes may be useful for many applications. We developed a novel injectable bone substitute based on osteoblast-fibrin glue suspension and calcium phosphate bone cement (BC). Human osteoblasts were isolated from trabecular bone samples and cultured under standard conditions. Osteoblasts were suspended in fibrinogen solution (FS). BC was cured with thrombin solution. 8 × 4 mm injectable bone discs were prepared using silicon molds and a custom-made applicator device. Discs containing BC, BC/FS, or BC/FS/osteoblasts were implanted subcutaneously into athymic nude mice. After 3, 9 and 24 weeks, specimens were explanted and subjected to morphologic and biomechanical evaluation. In vitro fibrin gel-embedded osteoblasts displayed a differentiated phenotype as evidenced by alkaline phosphatase, collagen type 1 and von Kossa stains. A proportion of osteoblasts appeared morphologically intact over a 3-day in vitro period following application into the BC. BC/FS and BC/FS/osteoblast discs were sparsely infiltrated with vascularized connective tissue. There was no bone formation in implants from all groups. However, positive von Kossa staining only in BC/FS/osteoblast groups suggests engraftment of at least some of the transplanted cells. Biomechanical evaluation demonstrated initial stability of the composites. Young’s modulus and maximal load did not differ significantly in the BC/FS and BC/FS/osteoblast groups. The practicability of osteoblast-containing injectable bone could be demonstrated. The dense microstructure and the suboptimal initial vascularization of the composites may explain the lack of bone formation. Modifications with regard to enhanced osteoblast survival are mandatory for a possible application as injectable osteogenic bone replacement system.

Keywords:
Tissue engineering, Injectable bone, Fibrin gel
1.
Bach, A.D., H. Bannasch, T.J. Galla, K.M. Bittner, G.B. Stark (2001) Fibrin glue as matrix for cultured autologous urothelial cells in urethral reconstruction. Tissue Eng 7: 45–53.
2.
Barone, C.M., D.F. Jimenez, M.T. Boschert, B.W. Beckert (2000) BoneSource solidification: A comparison between water and sodium phosphate as the solvent. J Craniofac Surg 11: 495–497.
3.
Bruder, S.P., B.S. Fox (1999) Tissue engineering of bone. Cell based strategies. Clin Orthop Relat Res 367 suppl: S68–S83.
4.
Costantino, P.D., C.D. Friedman, K. Jones, L.C. Chow, G.A. Sisson (1992) Experimental hydroxyapatite cement cranioplasty. Plast Reconstr Surg 90: 174–185.
5.
Crane, G.M., S.L. Ishaug, A.G. Mikos (1995) Bone tissue engineering. Nat Med 1: 1322–1324.
6.
Ebraheim, N.A., H. Elgafy, R. Xu (2001) Bone-graft harvesting from iliac and fibular donor sites: Techniques and complications. J Am Acad Orthop Surg 9: 210–218.
7.
Frankenburg, E.P., S.A. Goldstein, T.W. Bauer, S.A. Harris, R.D. Poser (1998) Biomechanical and histological evaluation of a calcium phosphate cement. J Bone Joint Surg Am 80: 1112–1124.
8.
Friedman, C.D., P.D. Costantino, S. Takagi, L.C. Chow (1998) BoneSource hydroxyapatite cement: A novel biomaterial for craniofacial skeletal tissue engineering and reconstruction. J Biomed Mater Res 43: 428–432.
9.
Frosch, K.H., F. Barvencik, C.H. Lohmann, V. Viereck, H. Siggelkow, J. Breme, K. Dresing, K.M. Sturmer (2002) Migration, matrix production and lamellar bone formation of human osteoblast-like cells in porous titanium implants. Cells Tissues Organs 170: 214–227.
10.
Gao, J., J.E. Dennis, L.A. Solchaga, A.S. Awadallah, V.M. Goldberg, A.I. Caplan (2001) Tissue-engineered fabrication of an osteochondral composite graft using rat bone marrow-derived mesenchymal stem cells. Tissue Eng 7: 363–371.
11.
Gittens, S.A., H. Uludag (2001) Growth factor delivery for bone tissue engineering. J Drug Target 9: 407–429.
12.
Haisch, A., A. Loch, J. David, A. Pruss, R. Hansen, M. Sittinger (2000) Preparation of a pure autologous biodegradable fibrin matrix for tissue engineering. Med Biol Eng Comput 38: 686–689.
13.
Harper, E.J. (1998) Bioactive bone cements. Proc Inst Mech Eng 212: 113–120.
14.
Isogai, N., W.J. Landis, R. Mori, Y. Gotoh, L.C. Gerstenfeld, J. Upton, J.P. Vacanti (2000) Experimental use of fibrin glue to induce site-directed osteogenesis from cultured periosteal cells. Plast Reconstr Surg 105: 953–963.
15.
Jarcho, M. (1986) Biomaterial aspects of calcium phosphates. Properties and applications. Dent Clin North Am 30: 25–47.
16.
Jupiter, J.B., S. Winters, S. Sigman, C. Lowe, C. Pappas, A.L. Ladd, M. Van Wagoner, S.T. Smith (1997) Repair of five distal radius fractures with an investigational cancellous bone cement: A preliminary report. J Orthop Trauma 11: 110–116.
17.
Kaiser, H.W., G.B. Stark, J. Kopp, A. Balcerkiewicz, G. Spilker, H.W. Kreysel (1994) Cultured autologous keratinocytes in fibrin glue suspension, exclusively and combined with STS-allograft (preliminary clinical and histological report of a new technique). Burns 20: 23–29.
18.
Knabe, C., F.C. Driessens, J.A. Planell, R. Gildenhaar, G. Berger, D. Reif, R. Fitzner, R.J. Radlanski, U. Gross (2000) Evaluation of calcium phosphates and experimental calcium phosphate bone cements using osteogenic cultures. J Biomed Mater Res 52: 498–508.
19.
Kneser, U., P.M. Kaufmann, H.C. Fiegel, J.M. Pollok, D. Kluth, H. Herbst, X. Rogiers (1999) Long-term differentiated function of heterotopically transplanted hepatocytes on three-dimensional polymer matrices. J Biomed Mater Res 47: 494–503.
20.
Kneser, U., D.J. Schaefer, B. Munder, C. Klemt, C. Andree, G.B. Stark (2002) Tissue engineering of bone. Min Invas Ther Allied Technol 11: 107–116.
21.
Krebsbach, P.H., S.A. Kuznetsov, K. Satomura, R.V. Emmons, D.W. Rowe, P.G. Robey (1997) Bone formation in vivo: Comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation 63: 1059–1069.
22.
Kreklau, B., M. Sittinger, M.B. Mensing, C. Voigt, G. Berger, G.R. Burmester, R. Rahmanzadeh, U. Gross (1999) Tissue engineering of biphasic joint cartilage transplants. Biomaterials 20: 1743–1749.
23.
Kuboki, Y., Q. Jin, H. Takita (2001) Geometry of carriers controlling phenotypic expression in BMP-induced osteogenesis and chondrogenesis. J Bone Joint Surg Am 83-A(suppl 1): S105–115.
24.
Langer, R., J.P. Vacanti (1993) Tissue engineering. Science 260: 920–926.
25.
Laurie, S.W., L.B. Kaban, J.B. Mulliken, J.E. Murray (1984) Donor-site morbidity after harvesting rib and iliac bone. Plast Reconstr Surg 73: 933–938.
26.
Lee, K.Y., E. Alsberg, D.J. Mooney (2001) Degradable and injectable poly(aldehyde guluronate) hydrogels for bone tissue engineering. J Biomed Mater Res 56: 228–233.
27.
Lewis, G. (1997) Properties of acrylic bone cement: State of the art review. J Biomed Mater Res 38: 155–182.
28.
Muraglia, A., I. Martin, R. Cancedda, R. Quarto (1998) A nude mouse model for human bone formation in unloaded conditions. Bone 22: 131S–134S.
29.
Murphy, W.L., R.G. Dennis, J.L. Kileny, D.J. Mooney (2002) Salt fusion: An approach to improve pore interconnectivity within tissue engineering scaffolds. Tissue Eng 8: 43–52.
30.
Orban, J.M., K.G. Marra, J.O. Hollinger (2002) Composition options for tissue-engineered bone. Tissue Eng 8: 529–539.
31.
Oreffo, R.O., F.C. Driessens, J.A. Planell, J.T. Triffitt (1998) Effects of novel calcium phosphate cements on human bone marrow fibroblastic cells. Tissue Eng 4: 293–303.
32.
Payne, R.G., J.S. McGonigle, M.J. Yaszemski, A.W. Yasko, A.G. Mikos (2002a) Development of an injectable, in situ crosslinkable, degradable polymeric carrier for osteogenic cell populations. 2. Viability of encapsulated marrow stromal osteoblasts cultured on crosslinking poly(propylene fumarate). Biomaterials 23: 4373–4380.
33.
Payne, R.G., J.S. McGonigle, M.J. Yaszemski, A.W. Yasko, A.G. Mikos (2002b) Development of an injectable, in situ crosslinkable, degradable polymeric carrier for osteogenic cell populations. 3. Proliferation and differentiation of encapsulated marrow stromal osteoblasts cultured on crosslinking poly(propylene fumarate). Biomaterials 23: 4381–4387.
34.
Payne, R.G., M.J. Yaszemski, A.W. Yasko, A.G. Mikos (2002c) Development of an injectable, in situ crosslinkable, degradable polymeric carrier for osteogenic cell populations. 1. Encapsulation of marrow stromal osteoblasts in surface crosslinked gelatin microparticles. Biomaterials 23: 4359–4371.
35.
Perka, C., U. Arnold, R.S. Spitzer, K. Lindenhayn (2001) The use of fibrin beads for tissue engineering and subsequential transplantation. Tissue Eng 7: 359–361.
36.
Perka, C., O. Schultz, R.S. Spitzer, K. Lindenhayn, G.R. Burmester, M. Sittinger (2000) Segmental bone repair by tissue-engineered periosteal cell transplants with bioresorbable fleece and fibrin scaffolds in rabbits. Biomaterials 21: 1145–1153.
37.
Quarto, R., M. Mastrogiacomo, R. Cancedda, S.M. Kutepov, V. Mukhachev, A. Lavroukov, E. Kon, M. Marcacci (2001) Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 344: 385–386.
38.
Reddi, A.H. (2000) Morphogenesis and tissue engineering of bone and cartilage: Inductive signals, stem cells, and biomimetic biomaterials. Tissue Eng 6: 351–359.
39.
Ripamonti, U., S.S. Ma, A.H. Reddi (1992) Induction of bone in composites of osteogenin and porous hydroxyapatite in baboons. Plast Reconstr Surg 89: 731–740.
40.
Schaefer, D.J., B. Munder, M. Voigt, G.B. Stark (1998) Proliferation of human osteoblastic cells and synthesis of extracellular bone matrix on biomaterials. Mater Res Soc Symp Proc 530: 105–109.
41.
Schmitz, J.P., J.O. Hollinger, S.B. Milam (1999) Reconstruction of bone using calcium phosphate bone cements: A critical review. J Oral Maxillofac Surg 57: 1122–1126.
42.
Shin, H., P. Quinten Ruhe, A.G. Mikos, J.A. Jansen (2003) In vivo bone and soft tissue response to injectable, biodegradable oligo(poly (ethylene glycol) fumarate) hydrogels. Biomaterials 24: 3201–3211.
43.
Stelnicki, E.J., D.K. Ousterhout (1997) Hydroxyapatite paste (BoneSource) used as an onlay implant for supraorbital and malar augmentation. J Craniofac Surg 8: 367–372.
44.
Temenoff, J.S., A.G. Mikos (2000) Injectable biodegradable materials for orthopedic tissue engineering. Biomaterials 21: 2405–2412.
45.
Vacanti, C.A., L.J. Bonassar, M.P. Vacanti, J. Shufflebarger (2001) Replacement of an avulsed phalanx with tissue-engineered bone. N Engl J Med 344: 1511–1514.
46.
Weaker, F.J., L. Richardson (1979) Staining calcified tissues in plastic embedding medium. Am J Med Technol 45: 363–365.
47.
Wintermantel, E., J. Mayer, J. Blum, K.L. Eckert, P. Luscher, M. Mathey (1996) Tissue engineering scaffolds using superstructures. Biomaterials 17: 83–91.
48.
Yamada, Y., J.S. Boo, R. Ozawa, T. Nagasaka, Y. Okazaki, K. Hata, M. Ueda (2003) Bone regeneration following injection of mesenchymal stem cells and fibrin glue with a biodegradable scaffold. J Craniomaxillofac Surg 31: 27–33.
49.
Yang, S., K.F. Leong, Z. Du, C.K. Chua (2001) The design of scaffolds for use in tissue engineering. 1. Traditional factors. Tissue Eng 7: 679–689.
© 2005 S. Karger AG, Basel
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.